• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

川崎病后冠状动脉瘤的中期并发症:来自国际川崎病注册研究。

Medium-Term Complications Associated With Coronary Artery Aneurysms After Kawasaki Disease: A Study From the International Kawasaki Disease Registry.

机构信息

Division of Cardiology Department of Pediatrics University of Toronto The Hospital for Sick Children Toronto Ontario Canada.

Boston Children's Hospital Harvard Medical School Boston MA.

出版信息

J Am Heart Assoc. 2020 Aug 4;9(15):e016440. doi: 10.1161/JAHA.119.016440. Epub 2020 Jul 28.

DOI:10.1161/JAHA.119.016440
PMID:32750313
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7792232/
Abstract

Background Coronary artery aneurysms (CAAs) may occur after Kawasaki disease (KD) and lead to important morbidity and mortality. As CAA in patients with KD are rare and heterogeneous lesions, prognostication and risk stratification are difficult. We sought to derive the cumulative risk and associated factors for cardiovascular complications in patients with CAAs after KD. Methods and Results A 34-institution international registry of 1651 patients with KD who had CAAs (maximum CAA score ≥2.5) was used. Time-to-event analyses were performed using the Kaplan-Meier method and Cox proportional hazard models for risk factor analysis. In patients with CAA scores ≥10, the cumulative incidence of luminal narrowing (>50% of lumen diameter), coronary artery thrombosis, and composite major adverse cardiovascular complications at 10 years was 20±3%, 18±2%, and 14±2%, respectively. No complications were observed in patients with a CAA score <10. Higher CAA score and a greater number of coronary artery branches affected were associated with increased risk of all types of complications. At 10 years, normalization of luminal diameter was noted in 99±4% of patients with small (2.5≤<5.0), 92±1% with medium (5.0≤<10), and 57±3% with large CAAs (≥10). CAAs in the left anterior descending and circumflex coronary artery branches were more likely to normalize. Risk factor analysis of coronary artery branch level outcomes was performed with a total of 893 affected branches with score ≥10 in 440 patients. In multivariable regression models, hazards of luminal narrowing and thrombosis were higher for patients with CAAs of the right coronary artery and left anterior descending branches, those with CAAs that had complex architecture (other than isolated aneurysms), and those with CAAs with scores ≥20. Conclusions For patients with CAA after KD, medium-term risk of complications is confined to those with maximum CAA scores ≥10. Further risk stratification and close follow-up, including advanced imaging, in patients with large CAAs is warranted.

摘要

背景

川崎病(KD)后可发生冠状动脉瘤(CAA),并导致重要的发病率和死亡率。由于 KD 患者的 CAA 是罕见且异质性的病变,因此预后和风险分层较为困难。我们旨在探讨 KD 后 CAA 患者发生心血管并发症的累积风险及相关因素。

方法和结果

我们使用了一个由 1651 例 KD 合并 CAA(最大 CAA 评分≥2.5)患者组成的 34 家机构国际注册中心,采用 Kaplan-Meier 方法进行时间事件分析,并采用 Cox 比例风险模型进行危险因素分析。在 CAA 评分≥10 的患者中,10 年内管腔狭窄(管腔直径缩小>50%)、冠状动脉血栓形成和复合主要不良心血管并发症的累积发生率分别为 20±3%、18±2%和 14±2%。CAA 评分<10 的患者未观察到任何并发症。较高的 CAA 评分和受影响的冠状动脉分支数量与所有类型并发症的风险增加相关。10 年后,小(2.5< <5.0)、中(5.0< <10)和大(≥10)CAA 的患者管腔直径正常率分别为 99±4%、92±1%和 57±3%。左前降支和回旋支 CAA 更有可能恢复正常。对 440 例患者中 893 个 CAA 分支(共 440 例患者,评分≥10)进行了冠状动脉分支水平结局的危险因素分析。多变量回归模型显示,右冠状动脉和前降支 CAA、结构复杂(非孤立性动脉瘤)的 CAA 以及评分≥20 的 CAA 的患者,管腔狭窄和血栓形成的风险更高。

结论

KD 后 CAA 患者的中期并发症风险仅限于最大 CAA 评分≥10 的患者。对于大 CAA 患者,需要进一步进行风险分层和密切随访,包括高级影像学检查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b0/7792232/d4ec9abb30b8/JAH3-9-e016440-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b0/7792232/80545ceff247/JAH3-9-e016440-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b0/7792232/4b480a32fd00/JAH3-9-e016440-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b0/7792232/d4ec9abb30b8/JAH3-9-e016440-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b0/7792232/80545ceff247/JAH3-9-e016440-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b0/7792232/4b480a32fd00/JAH3-9-e016440-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b0/7792232/d4ec9abb30b8/JAH3-9-e016440-g003.jpg

相似文献

1
Medium-Term Complications Associated With Coronary Artery Aneurysms After Kawasaki Disease: A Study From the International Kawasaki Disease Registry.川崎病后冠状动脉瘤的中期并发症:来自国际川崎病注册研究。
J Am Heart Assoc. 2020 Aug 4;9(15):e016440. doi: 10.1161/JAHA.119.016440. Epub 2020 Jul 28.
2
Time Course of Coronary Artery Aneurysms in Kawasaki Disease.川崎病冠状动脉瘤的时间进程。
J Pediatr. 2021 Mar;230:133-139.e2. doi: 10.1016/j.jpeds.2020.12.004. Epub 2020 Dec 8.
3
Analysis of Coronary Arterial Aneurysm Regression in Patients With Kawasaki Disease by Aneurysm Severity: Factors Associated With Regression.冠状动脉瘤严重程度对川崎病患者冠状动脉瘤消退的影响分析:消退相关因素。
J Am Heart Assoc. 2023 Feb 7;12(3):e022417. doi: 10.1161/JAHA.121.022417. Epub 2023 Jan 31.
4
Etiology and prognosis of non-Kawasaki disease induced coronary aneurysms in children: a retrospective case series study.儿童非川崎病相关性冠状动脉瘤的病因和预后:一项回顾性病例系列研究。
Eur J Pediatr. 2024 Oct;183(10):4229-4234. doi: 10.1007/s00431-024-05666-5. Epub 2024 Jul 11.
5
Association of Severity of Coronary Artery Aneurysms in Patients With Kawasaki Disease and Risk of Later Coronary Events.川崎病患者冠状动脉瘤严重程度与后期冠状动脉事件风险的相关性研究。
JAMA Pediatr. 2018 May 7;172(5):e180030. doi: 10.1001/jamapediatrics.2018.0030.
6
Predicting Coronary Artery Aneurysms in Kawasaki Disease at a North American Center: An Assessment of Baseline Scores.北美某中心对川崎病患者冠状动脉瘤的预测:基线评分评估
J Am Heart Assoc. 2017 May 31;6(6):e005378. doi: 10.1161/JAHA.116.005378.
7
A registry study of Kawasaki disease patients with coronary artery aneurysms (KIDCAR): a report on a multicenter prospective registry study three years after commencement.一项关于川崎病合并冠状动脉瘤患者的注册研究(KIDCAR):启动三年后的多中心前瞻性注册研究报告
Eur J Pediatr. 2023 Feb;182(2):633-640. doi: 10.1007/s00431-022-04719-x. Epub 2022 Nov 25.
8
Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.川崎病冠状动脉瘤:美国人群中进展性疾病和不良心脏事件的危险因素。
J Am Heart Assoc. 2016 Sep 15;5(9):e003289. doi: 10.1161/JAHA.116.003289.
9
Low-Molecular-Weight Heparin vs Warfarin for Thromboprophylaxis in Children With Coronary Artery Aneurysms After Kawasaki Disease: A Pragmatic Registry Trial.低分子肝素与华法林预防川崎病后冠状动脉瘤患儿血栓形成的比较:一项实用登记试验。
Can J Cardiol. 2020 Oct;36(10):1598-1607. doi: 10.1016/j.cjca.2020.01.016. Epub 2020 Jul 1.
10
Improved classification of coronary artery abnormalities based only on coronary artery z-scores after Kawasaki disease.仅基于川崎病后冠状动脉z评分对冠状动脉异常进行的改良分类。
Pediatr Cardiol. 2010 Feb;31(2):242-9. doi: 10.1007/s00246-009-9599-7. Epub 2009 Dec 19.

引用本文的文献

1
Comprehensive assessment of patients with Kawasaki disease without coronary artery aneurysm.对无冠状动脉瘤的川崎病患者的综合评估
Quant Imaging Med Surg. 2025 Sep 1;15(9):8348-8358. doi: 10.21037/qims-2024-2772. Epub 2025 Aug 13.
2
Five-Year Experience of Etanercept as Adjunct to Intravenous Immunoglobulin for Kawasaki Disease with Coronary Artery Involvement.依那西普作为静脉注射免疫球蛋白辅助药物治疗川崎病合并冠状动脉病变的五年经验
J Pediatr Clin Pract. 2025 Jul 16;17:200165. doi: 10.1016/j.jpedcp.2025.200165. eCollection 2025 Sep.
3
Risk factors associated with persistent coronary artery lesions in children with Kawasaki disease in an Italian cohort.

本文引用的文献

1
Difference Between Persistent Aneurysm, Regressed Aneurysm, and Coronary Dilation in Kawasaki Disease: An Optical Coherence Tomography Study.川崎病患者持续性动脉瘤、退行性动脉瘤与冠状动脉扩张的光学相干断层成像研究。
Can J Cardiol. 2018 Sep;34(9):1120-1128. doi: 10.1016/j.cjca.2018.05.021. Epub 2018 Jun 1.
2
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.川崎病的诊断、治疗和长期管理:美国心脏协会发布的一份面向医疗保健专业人员的科学声明。
Circulation. 2017 Apr 25;135(17):e927-e999. doi: 10.1161/CIR.0000000000000484. Epub 2017 Mar 29.
3
意大利队列中川崎病患儿持续性冠状动脉病变的相关危险因素。
Eur J Pediatr. 2025 May 31;184(6):377. doi: 10.1007/s00431-025-06162-0.
4
Systemic Arterial Aneurysms in Kawasaki Disease: An Important Evidence Gap.川崎病中的系统性动脉动脉瘤:一个重要的证据空白。
Pediatr Cardiol. 2025 May 12. doi: 10.1007/s00246-025-03888-4.
5
Spectrum of Coronary Artery Involvement With Multisystem Inflammatory Syndrome in Children Versus Kawasaki Disease.儿童多系统炎症综合征与川崎病冠状动脉受累情况对比
J Am Heart Assoc. 2025 May 6;14(9):e037761. doi: 10.1161/JAHA.124.037761. Epub 2025 Apr 23.
6
Case Report: Late coronary complication of Kawasaki disease.病例报告:川崎病的晚期冠状动脉并发症
Front Pediatr. 2025 Mar 4;13:1527714. doi: 10.3389/fped.2025.1527714. eCollection 2025.
7
Pharmacoeconomic Analysis and Considerations for the Management of Kawasaki Disease in the Arab Countries-A Multinational, Multi-Institutional Project of the Kawasaki Disease Arab Initiative (Kawarabi) (A Project Methodology Paper).阿拉伯国家川崎病管理的药物经济学分析与考量——川崎病阿拉伯倡议(Kawarabi)的一项多国多机构项目(项目方法文件)
Turk Arch Pediatr. 2025 Mar 3;60(2):172-181. doi: 10.5152/TurkArchPediatr.2025.24248.
8
Specific Morphology of Coronary Artery Aneurysms in Mainly White Patients With Kawasaki Disease: Initial Data From the Cardiac Catheterization in Kawasaki Disease Registry.川崎病患者中以白种人为主的冠状动脉瘤的特定形态:川崎病血管造影登记研究的初步数据。
J Am Heart Assoc. 2024 Nov 5;13(21):e034248. doi: 10.1161/JAHA.124.034248. Epub 2024 Oct 25.
9
Coronary Artery Aneurysm or Ectasia as a Form of Coronary Artery Remodeling: Etiology, Pathogenesis, Diagnostics, Complications, and Treatment.冠状动脉瘤或扩张作为冠状动脉重塑的一种形式:病因、发病机制、诊断、并发症及治疗
Biomedicines. 2024 Sep 2;12(9):1984. doi: 10.3390/biomedicines12091984.
10
Advancing Kawasaki Disease Research in the Arab World: Scoping Literature Review Analysis with Emphasis on Giant Coronary Aneurysms.推进阿拉伯世界的川崎病研究:以巨大冠状动脉瘤为重点的文献综述分析
Pediatr Cardiol. 2024 Jul 22. doi: 10.1007/s00246-024-03589-4.
Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.
川崎病冠状动脉瘤:美国人群中进展性疾病和不良心脏事件的危险因素。
J Am Heart Assoc. 2016 Sep 15;5(9):e003289. doi: 10.1161/JAHA.116.003289.
4
Coronary Artery Aneurysm Measurement and Z Score Variability in Kawasaki Disease.川崎病中冠状动脉瘤的测量及Z评分变异性
J Am Soc Echocardiogr. 2016 Feb;29(2):150-7. doi: 10.1016/j.echo.2015.08.013. Epub 2015 Sep 19.
5
Predictors of coronary artery visualization in Kawasaki disease.川崎病冠状动脉可视化的预测因素。
J Am Soc Echocardiogr. 2011 Jan;24(1):53-9. doi: 10.1016/j.echo.2010.10.015.
6
Improved classification of coronary artery abnormalities based only on coronary artery z-scores after Kawasaki disease.仅基于川崎病后冠状动脉z评分对冠状动脉异常进行的改良分类。
Pediatr Cardiol. 2010 Feb;31(2):242-9. doi: 10.1007/s00246-009-9599-7. Epub 2009 Dec 19.
7
The adult after kawasaki disease the risks for late coronary events.川崎病成年患者发生晚期冠状动脉事件的风险。
J Am Coll Cardiol. 2009 Nov 17;54(21):1921-3. doi: 10.1016/j.jacc.2009.06.057.
8
Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.研究电子数据采集(REDCap)——一种用于提供转化研究信息学支持的元数据驱动方法和工作流程。
J Biomed Inform. 2009 Apr;42(2):377-81. doi: 10.1016/j.jbi.2008.08.010. Epub 2008 Sep 30.
9
Bootstrap model selection had similar performance for selecting authentic and noise variables compared to backward variable elimination: a simulation study.与向后变量消除法相比,自举模型选择在选择真实变量和噪声变量方面具有相似的性能:一项模拟研究。
J Clin Epidemiol. 2008 Oct;61(10):1009-17.e1. doi: 10.1016/j.jclinepi.2007.11.014. Epub 2008 Jun 9.
10
Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements.川崎病患儿的冠状动脉受累情况:基于系列标准化测量分析的危险因素
Circulation. 2007 Jul 10;116(2):174-9. doi: 10.1161/CIRCULATIONAHA.107.690875. Epub 2007 Jun 18.